Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Retained Earnings (2019 - 2025)

Biodesix's Retained Earnings history spans 7 years, with the latest figure at -$497.8 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 7.62% year-over-year to -$497.8 million; the TTM value through Dec 2025 reached -$497.8 million, down 7.62%, while the annual FY2025 figure was -$497.8 million, 7.62% down from the prior year.
  • Retained Earnings reached -$497.8 million in Q4 2025 per BDSX's latest filing, down from -$493.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$265.8 million in Q1 2021 to a low of -$497.8 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$392.9 million, with a median of -$405.0 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: dropped 21.67% in 2022, then dropped 7.62% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$302.0 million in 2021, then fell by 21.67% to -$367.4 million in 2022, then decreased by 14.19% to -$419.6 million in 2023, then dropped by 10.23% to -$462.5 million in 2024, then decreased by 7.62% to -$497.8 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Retained Earnings are -$497.8 million (Q4 2025), -$493.8 million (Q3 2025), and -$485.1 million (Q2 2025).